The ability of LAPTM4B to modulate key signaling pathways, such as PI3K/AKT and EGFR, and affect autophagy and chemoresistance, and its ability to interact with autophagy-associated proteins and ceramides, further illustrates the complexity of the role of LAPTM4B in tumor cell survival. The gene discussed is AKT1; the disease is neoplasm.